GLP-1 drugs like Ozempic and Zepbound treat diseases related to blood sugar and weight management. Professor Joe Balagtas ...

The proportion of obese Indians has risen from 25 per cent in 2013 to 40 per cent in 2023, highlighting the need for ...

Food manufacturers are trying to whip themselves up a forkful of the slimming trend — but nutrition experts aren't giving ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

Just eight seconds into the start of the 2025 award show season, Nikki Glaser, the host of the 82nd Golden Globes, dubbed the ...

The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...

Kassandra – stock.adobe.com “Because GLP-1s suppress appetite, people taking these medications should be mindful about including nutrient-dense foods to make sure they reach their daily goals ...

was cleared to treat moderate to severe forms of the sleep condition in people with obesity. It should be used with a reduced-calorie diet and increased physical activity, drugmaker Eli Lilly said ...

So much so that Lilly, the medication company that manufactures Zepbound ... according to People. The actress, who was nominated for her work on Matlock, debuted a 100-pound weight loss in September, ...

“The term osteoporosis screening refers to use of bone density, x-ray studies or other tools to identify persons at an increased risk of fractures or bone breaks,” Dr. Thomas Weber, an endocrinologist ...